“NEW THERAPIES IN THE 21ST CENTURY: CHALLENGES FOR HOSPITAL PHARMACY”

From medieval times there has been a close connection between pharmacy skills and the range of therapies available for the patient. The earliest pharmacopoeias described what were to be generally accepted “active ingredients” in combination with recommendations on how to handle them and ways to formulate them into ready-to-use medicines. The challenge for the pharmacist in those days was to conduct the preparation of medicines under public control at the town hall when unicorn, gold or other precious potent ingredients were believed to be essential for the clinical result.

Basic history has not changed over the years, but the players in the games have increased both in number and in professional background.

New therapies come to the hospital pharmacy and are today an important factor in the develop-ment of the present and future daily life of pharmacists. Complex therapies, including drugs with many targets and in some cases designed for individual metabolism of the single patient, form a part of the future, together with individual treatments put up close to the patient’s bedside.

New skills in hospital pharmacy production are demanded and, at the same time, documentation and quality assurance according to European rules for GMP are mandatory tools for the hospital pharmacy.

Managing the costs of expensive drugs is a well-known chapter in the book of the pharmacy man-ager. However, the demand for transparency in the purchasing process comes now not only from the hospital director but also from other players, including both industry and EU regulation.

Are we as pharmacists in the new Europe ready for this development?

Vagn Handlos
President of the Scientific Committee of the EAHP

SCIENTIFIC PROGRAMME

WEDNESDAY 21 MARCH 2007

14.00-16.00 Opening Ceremony
Keynote presentation
How is genome technology affecting therapy in hospital pharmacy practice?

Speaker: William E Evans, PharmD, St Jude Children's Research Hospital, Memphis, TN, USA

16.00-16.30 Coffee break
Opening of the Exhibition

16.30-18.00 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1: Drugs of the 21st century: biopharmaceuticals and biosimilars/ Level: Advanced
Speaker A: Professor Roger L Tredree, St George’s Hospital, London, UK
Speaker B: Professor Huub Schellekens, Institute of Innovative Studies, University of Utrecht, Utrecht, The Netherlands

Seminar 4: The EAHP 2005 Survey: trends of European hospital pharmacy in the new century / Level: Introductory
Speaker A: Dr Tajda Miharija-Gala, University Medical Centre Ljubljana, Ljubljana, Slovenia and Director of Professional and Practice Aspects, EAHP
Speaker B: To be confirmed

Seminar 6: The GMP challenge: Future for production and reconstitution in Hospital Pharmacy / Level: Intermediate
Speaker A: Professor Vagn Handlos, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Kristina Thomsen, Roskilde Hospital, Denmark

Seminar 9: Drugs available in the EU – future shortage? / Level: Introductory
Speaker A: Dr Walter Deutschmann, Klinikum Bremen Mitte, Bremen, Germany
Speaker B: Rui Dos Santos Ivo, European Commission, Brussels, Belgium

16.30-18.00 Satellite Symposium: Biocompatibles: Drug Eluting Beads, A novel Drug Delivery Embolisation System in Oncology

18.00-18.30 Break

18.30-20.00 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 3: Haemato-oncology: cutting edge diagnosis translated in tailor-made therapy / Level: Advanced
Speaker A: Dr Maria Guadalupe Salta, Instituto Português de Oncologia de Francisco Gentil, Lisbon, Portugal
Speaker B: Professor John Goldman, Imperial College, London, UK

Seminar 10: Reengineering hospital pharmacy in Europe: changing from cost to care centres / Level: Intermediate
Speaker A: Dr Jorgen Garnak, IMS Health, London, UK
Speaker B: Dr Maria Antònia Mangues, Hospital de la Sta Creu I St Pau, Barcelona, Spain

Seminar 12: Is purchasing drugs a role for the hospital pharmacy in the future? / Level: Introductory
Speaker A: Flemming Sonne, Amgros I/S, Copenhagen, Denmark
Speaker B: Dr Michael Baehr, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Seminar 8: How does hospital accreditation affect the hospital pharmacies in Europe? / Level: Intermediate
Speaker A: Dr Helle Mc Nulty, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Dr David Marx, Charles University, Prague, Czech Republic

 
18.30-20.00 Satellite Symposium: Amgen: Biosimilars - Complexity and concerns

20.00-21.30 Welcome reception in the exhibition area

THURSDAY 22 MARCH 2007

09.00-10.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 9: Drugs available in the EU – future shortage? / Level: Introductory
Speaker A: Dr Walter Deutschmann, Klinikum Bremen Mitte, Bremen, Germany
Speaker B: Rui Dos Santos Ivo, European Commission, Brussels, Belgium

Seminar 4: The EAHP 2005 Survey: trends of European hospital pharmacy in the new century / Level: Introductory
Speaker A: Dr Tajda Miharija-Gala, University Medical Centre Ljubljana, Ljubljana, Slovenia and Director of Professional and Practice Aspects, EAHP
Speaker B: To be confirmed

Seminar 7: National presidents’ seminar: patient safety in the daily life of European hospitals / Level: Introductory
Speaker A: Dr Jochen Schnurrer, Klinikum Region Hannover, Laatzen, Germany
Speaker B: Veronica Treacy, St James Hospital, Dublin, Ireland
Speaker C: Dr María José Tamés, Instituto Oncológico, San Sebastian, Spain

Seminar 12: Is purchasing drugs a role for the hospital pharmacy in the future? / Level: Introductory
Speaker A: Flemming Sonne, Amgros I/S, Copenhagen, Denmark
Speaker B: Dr Michael Baehr, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

09.00-10.30 Satellite Symposium: TEVA: BioGeneric drugs: the next breakthrough

10.30-11.30 Coffee break

11.30-12.30 Keynote presentation
How are new pharmaceuticals tested in humans after the March 2006 tragic outcome in London?

Speaker: Dr Nirmala Bhogal, FRAME, Nottingham, UK

12.30-14.00 Lunch

14.00-15.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 3: Haemato-oncology: cutting edge diagnosis translated in tailor-made therapy / Level: Advanced
Speaker A: Dr Maria Guadalupe Salta, Instituto Português de Oncologia de Francisco Gentil, Lisbon, Portugal
Speaker B: Professor John Goldman, Imperial College, London, UK

Seminar 5: Incompatibility reactions in drug therapy – preventable medication errors / Level: Intermediate
Speaker A: Dr Karin Nemec, Donauspital, Vienna, Austria
Speaker B: Professor Stefan Mühlebach, Swissmedic, Bern, Switzerland

Seminar 8: How does hospital accreditation affect the hospital pharmacies in Europe? / Level: Intermediate
Speaker A: Dr Helle Mc Nulty, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Dr David Marx, Charles University, Prague, Czech Republic

Seminar 11: How to organize a clinical trial unit? / Level: Intermediate
Speaker A: Dr John Jolley, London, UK
Speaker B: Dr Monika Seibert-Grafe, Mainz, Germany

14.00-15.30 Satellite Symposium: IDIS: Chanllenges of using of unlicenced medicines throughout Europe

15.30-16.00 Coffee break

16.00-17.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1: Drugs of the 21st century: biopharmaceuticals and biosimilars / Level: Advanced
Speaker A: Professor Roger L Tredree, St George’s Hospital, London, UK
Speaker B: Professor Huub Schellekens, Institute of Innovative Studies, University of Utrecht, Utrecht, The Netherlands

Seminar 6: The GMP challenge: Future for production and reconstitution in Hospital Pharmacy / Level: Intermediate
Speaker A: Professor Vagn Handlos, H:S Pharmacy, Copenhagen, Denmark
Speaker B: Kristina Thomsen, Roskilde Hospital, Denmark

Seminar 2: Effect of genetic information on hospital pharmacy practice / Level: Intermediate
Speaker A: Dr Philippa Brice, UK
Speaker B: V'Iain Fenton-May, University of Wales, College of Medicine, Wales, UK

Seminar 10: Reengineering hospital pharmacy in Europe: changing from cost to care centres / Level: Intermediate
Speaker A: Dr Jorgen Garnak, IMS Health, London, UK
Speaker B: Dr Maria Antònia Mangues, Hospital de la Sta Creu I St Pau, Barcelona, Spain

16.00-17.30 Satellite Symposium: Celgene: Immunomodulary compounds: from basic science to clinical perspectives

17.30-18.00 Coffee break

18.00-19.30 Industry-sponsored satellite symposia

18.00-19.30 Satellite symposium: Cardinal Health: Planning for patient safety

18.00-19.30 Satellite symposium: Wyeth: The rational use of biologic therapy in inflammatory diseases

FRIDAY 23 MARCH 2007

9.00-10.30 Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 7: National presidents’ seminar: patient safety in the daily life of European hospitals / Level: Introductory
Speaker A: Dr Jochen Schnurrer, Klinikum Region Hannover, Laatzen, Germany
Speaker B: Veronica Treacy, St James Hospital, Dublin, Ireland
Speaker C: Dr María José Tamés, Instituto Oncológico, San Sebastian, Spain


Seminar 5: Incompatibility reactions in drug therapy – preventable medication errors / Level: Intermediate
Speaker A: Dr Karin Nemec, Donauspital, Vienna, Austria
Speaker B: Professor Stefan Mühlebach, Swissmedic, Bern, Switzerland

Seminar 11: How to organize a clinical trial unit? / Level: Intermediate
Speaker A: Dr John Jolley, London, UK
Speaker B: Dr Monika Seibert-Grafe, Mainz, Germany

Seminar 2: Effect of genetic information on hospital pharmacy practice / Level: Intermediate
Speaker A: Dr Philippa Brice, UK
Speaker B: V'Iain Fenton-May, University of Wales, College of Medicine, Wales, UK

09.00-10.30 Satellite symposium: ARX

10.30-11.30 Coffee break and poster session

11.30-12.30 Keynote presentation
Future for the free research and drug development

Speaker: Merrill Goozner, Center for Science in the Public Interest, Washington DC, USA

12.30-14.00 Closing Ceremony and Lunch

Scientific Committee:
Chairman: Professor Vagn N Handlos - Denmark
Members: Dr Eric Boury – France
Professor Toine Egberts – The Netherlands
Dr António Melo Gouveia - Portugal
Dr Marcela Heislerova - Czech Republic
Dr Torsten Hoppe-Tichy - Germany
Mr Robert McArtney – UK
Dr Kees Neef – The Netherlands
Dr Marie Claude Saux - France
Dr Kirsti Torniainen - Finland